Professional Documents
Culture Documents
Acute Pancreatitis
Acute Pancreatitis
Assoc. Prof.
S. Barbu 2011
Pancreatic diseases
S. Barbu 2011
Pancreatic diseases
Acute pancreatitis
Chronic pancreatitis
Correlations of
Pancreatic Diseases
Pancreatic Cancer
S. Barbu 2011
Pancreatic anatomy
S. Barbu 2011
Pancreatic anatomy
Pancreas = adnexal gland of the digestive tract - exocrine function - endocrine function
S. Barbu 2011
Pancreatic anatomy
S. Barbu 2011
Pancreatic secretion
The pancreatic gland contains three types of cells. The duct cells make up about 10% of the pancreas and
secrete solutions rich in bicarbonate.
S. Barbu 2011
Pancreatic secretion
Pancreatic anatomy
S. Barbu 2011
Acute Pancreatitis
Assoc. Prof.
S. Barbu 2011
Acute pancreatitis
the most terrible of all calamities that [affect] the abdominal viscera Sir Berkeley Moynihan (Ann Surg1925)
S. Barbu 2011
Acute pancreatitis
- 15 20% => necrosis (SAP severe acute pancreatitis)
40 70% => infection (week 3-4)
- Mortality
- Acute Pancreatitis = 10%
=> up to 50%
S. Barbu 2011
Acute pancreatitis
Course Objectives:
Definitions Etiology Pathology Symptoms Evolution Treatment Indications for Surgery
S. Barbu 2011
Acute pancreatitis
Pancreatitis
Pancreatitis
S. Barbu 2011
Pancreatitis
It can recur intermittently, contributing to the functional and morphologic loss of the gland, the pathological change referred to as chronic pancreatitis.
S. Barbu 2011
Acute Pancreatitis
Acute pancreatitis is an acute inflammatory process of the
pancreas, with variable involvement of: - other regional tissue or - remote organ systems.
S. Barbu 2011
Epidemiology
17 - 19/100,000 per year Peak incidence in 5th decade Incidence is Increasing 180,000 - >200,000 Hospital Admissions/Year (USA) 20% have a severe course
10-30% mortality for this group, which has not significantly
changed during the past few decades despite improvement in critical care and other interventions
S. Barbu 2011
Etiology
Etiologies: I get smashed
Idiopathic Gallstones (or other obstructive lesions) EtOH Trauma Steroids Mumps (& other viruses) Autoimmune (SLE, polyarteritis nodosa) Scorpion sting Hyper Ca, TG ERCP (5-10% of pts undergoing procedure) Drugs (thiazides, sulfonamides, ACE-I, NSAIDS, azathioprine)
S. Barbu 2011
Etiology
Alcohol (30-40%)
Mechanism not fully understood Alcohol metabolites are toxic
S. Barbu 2011
Etiology
Gallstones (35%-40%)
Gallstone pancreatitis risk is highest among patients with small GS < 5mm and with microlithiasis GS pancreatitis risk is also increased in women > 60 yrs
S. Barbu 2011
S. Barbu 2011
Etiology Trauma
Blunt Trauma
Automobile Bicycle handlebar injuries Abuse
Etiology Trauma
Iatrogenic Surgery
Surgery for duodenal ulcer splenectomy
S. Barbu 2011
S. Barbu 2011
Etiology Infection
Ascaris Campylobacter CMV Coxsackie B EBV Enterovirus HIV/AIDS Influenza MAC Measles Mumps Rubella Mycoplasma Rubeola Viral Hepatitis Varicella
S. Barbu 2011
Etiology-Anatomical Anomalies
Pancreas Divisum
Failure of dorsal and ventral fusion (5-15% of population)
Annular Pancreas Any Ductal Anomalies Sphincter of Oddi dysfunction Always consider a primary malignancy as a possible cause of new onset pancreatitis in
older patients Weight loss Recent Diabetes mellitus without other obvious risk factors
S. Barbu 2011
Etiology-Anatomical Anomalies
Pancreas Divisum
S. Barbu 2011
Etiology-Anatomical Anomalies
Annular Pancreas
S. Barbu 2011
Etiology Idiopathic
Experts suggest that idiopathic pancreatitis should account for no more than 5-10% of the total cases, yet the broadly quoted percentage in the literature at this time in the US is currently 20-25%.
S. Barbu 2011
Trivia
What is the name of the scorpion that causes pancreatitis?
Hint: you wont find it in the USA
S. Barbu 2011
Acute pancreatitis
Pathogenesis
1.A complicated pathophysiologic process 2.Enzyme autoactivation and self-digestion (key point) 3. Many agents participating in the process 4. Complete mechanism remaining unknown
S. Barbu 2011
S. Barbu 2011
1.hypertension in pancreatic duct 2.premature activation of pancreatic enzymes 3.injury to the lining of the pancreatic ducts pancreatic edema or necrosis MODS
S. Barbu 2011
Duodenal Reflux
duodenal enterokinase duct trypsinogen elastasinogen phospholipasogen lecithin
S. Barbu 2011
pancreatic
2.Alcohol Toxicity
stimulate the pancreas to secrete pancreatic hypertention duct and acinus rupture juice spillage spasm of the sphincter of oddi direct injury to pancreas
S. Barbu 2011
injure pancreatic
MSOF
Acute pancreatitis
Pathophys- insult leads to leakage of pancreatic enzymes into pancreatic and peripancreatic tissue leading to acute inflammatory reaction
S. Barbu 2011
Acute Interstitial edematous pancreatitis (IEP) => Mild acute pancreatitis (clinical)
Homogeneous enhancement of pancreatic parenchyma
S. Barbu 2011
S. Barbu 2011
Cullens sign
S. Barbu 2011
Differential
Not all inclusive, but may include:
Biliary disease Intestinal obstruction Mesenteric Ischemia Distal aortic dissection Perforated peptic ulcer (acute peritonitis) Intestinal oclusion by strangulation
S. Barbu 2011
Evaluation
amylaseNonspecific !!!
Amylase levels > 3x normal very suggestive of pancreatitis
May be normal in chronic pancreatitis!!!
Enzyme level severity False (-): acute on chronic (EtOH); HyperTG False (+): renal failure, other abdominal or salivary gland process, acidemia
lipase
More sensitive & specific than amylase
S. Barbu 2011
Evaluation
Other inflammatory markers will be elevated
CRP, IL-6, IL-8 (studies hoping to use these markers to aid in detecting severity of disease)
S. Barbu 2011
Radiographic Evaluation
AXR - sentinel loop or small bowel ileus US or CT may show enlarged pancreas with stranding, abscess, fluid collections, hemorrhage, necrosis or pseudocyst MRI/MRCP newest fad
Decreased nephrotoxicity from gadolinium Better visualization of fluid collections MRCP allows visualization of bile ducts for stones
Does not allow stone extraction or stent insertion
S. Barbu 2011
S. Barbu 2011
Acute Pancreatitis
Morbidity and mortality highest if necrosis present (especially if necrotic area infected)
Dual phase CT scan useful for initial eval to look for necrosis
However, necrosis may not be present for 48-72 hours
S. Barbu 2011
- Comparing patients for scientific purposes - Patients recruitment for clinical trials - Avoid unneccessary and expensive diagnostic and therapeutic procedures in mild cases
S. Barbu 2011
We should Thank
Bradley EL 3 rd.
S. Barbu 2011
1. 2.
S. Barbu 2011
Atlanta Definitions
Definitions for: Mild & Severe acute pancreatitis Acute fluid collections Pancreatic necrosis (sterile & infected) Acute pseudocyst Pancreatic abscess (diff from postop. Abscess)
(use of terms like pancreatic phlegmon, infected pseudocyst, etc should be discouraged)
S. Barbu 2011
Better understanding of the pathophysiology of acute necrotizing pancreatitis Improved diagnostic imaging of the pancreatic parenchyma and peripancreatic collections Development of minimally invasive techniques for the management of complications
Percutaneous (US or CT guided) drainage Endoscopic drainage Laparoscopic necrosectomy
S. Barbu 2011
May 2005: Working Group assembled Revision of the Atlanta Classification (Acute Pancreatitis Classification Working Group) Christos Dervenis, Athens/GR & Greg Tsiotos, Falirakon/GR IAP/EPC
Nov 2005: Decision to establish 2 Sub-Committees (coordinator C.Dervenis): Clinical (severity) Classification Peter Banks, Boston/USA
S. Barbu 2011
Approaches to Classification
This revised classification pertains primarily to adults (>18 years old) (certain definitions and scoring systems may not be applicable to the pediatric population)
S. Barbu 2011
New combined Clinical & Image-based Classification 1st Phase: Clinical Classification - 1
(2 of 3 findings)
2. 3.
Serum amylase / lipase activity >3 times upper normal value Characteristic findings on CECT
S. Barbu 2011
New combined Clinical & Image-based Classification 1st Phase: Clinical Classification - 2
Definition of onset
=> The time of onset of abdominal pain (not of admission) (The interval between onset of pain and admission should be noted precisely)
S. Barbu 2011
New combined Clinical & Image-based Classification 1st Phase: Clinical Classification - 3
Definition of severity*
Non-severe pancreatitis no organ failure Severe acute pancreatitis - persistence of organ failure >48 hr *Independent of imaging
S. Barbu 2011
Author
Positive
Negative
* early organ failure: within 72 hours after disease onset or admission SAP: severe acute pancreatitis; OF: organ failure; per: persistent; res: resolving
S. Barbu 2011
SEVERE ACUTE PANCREATITIS - scoring Modified Marshall Scoring System 0 1 2 3 4 Respiratory (PO2/FiO2)>400 301-400 201-300 101-200 <101 Renal (serum creatinine) 134 mol/L 1.0 mg% >90 CV (systolic BP) 134-169 170-310 310-439 >440 1.0-1.3 1.3-2.3 2.4-3.3 >3.3 >90 <90 pH<7.3 pH<7.2 81-120 13-15 41-80 10-12 21-50 6-9 <21 <6 Organ system
Dopamine Dopamine Dopamine <5 g/ml 15-14 >15 or Dobutamine Epi <0.1 Epi >0.1 or NEp <0.1 NEp >0.1 10-12 171-299 2.0-3.4 6-9 300-440 3.5-4.9 <6 >440 >5
Neurologic Glasgow coma score 15 13-14 Renal (serum creatinine) mol/L <110 100-170 mg% <1.2 1.2-1.9 or urine output
S. Barbu 2011
New combined Clinical & Image-based Classification 1st Phase: Severity defined by:
Conclusion:
=> 1st Phase: Severity defined by:
Persistent organ failure >2days death
S. Barbu 2011
New combined Clinical & Image-based Classification 1st Phase: Clinical Classification - 3
Definition of severity*
Non-severe pancreatitis no organ failure Severe acute pancreatitis - persistence of organ failure >48 hr
S. Barbu 2011
3.
S. Barbu 2011
1. Presence/absence of necrosis
(pancreatic and/or peripancreatic)
S. Barbu 2011
Transabdominal US and/or EUS can also be used (not so good) (may help to clarify the type of peripancreatic collection)
S. Barbu 2011
Goldstandard: Contrast-enhanced Computed Tomography (CECT) ERCP not recommended for Dg or Classification
- has No role in this image-based classification
S. Barbu 2011 Department of General, Visceral, and Vascular Surgery, UKS, Homburg/Saar, Germany
Conclus.: MRI is a reliable method for staging AP severity and predicting disease prognosis. MRI has fewer contraindications than CT.
Department of General, Visceral, and Vascular Surgery, UKS, Homburg/Saar, Germany S. Barbu 2011
S. Barbu 2011
Necrotizing Pancreatitis
Site:
Pancreatic + peripancreatic necrosis Peripancreatic alone (20%) better prognosis Pancreatic alone (rare)
Infection
Sterile necrosis Infected necrosis
(bubble gas inside the collection + Clinical signs of sepsis)
S. Barbu 2011
S. Barbu 2011
Necrosis - Infection
Depending on the stage (time from onset)
Primarily solid Semi-solid Liquefaction
Varying amount of suppuration
S. Barbu 2011
APFC (IEP)
APNPFC
WOPN
S. Barbu 2011
S. Barbu 2011
Fluid collections arising in patients with acute necrotizing pancreatitis are termed PNPFCs to distinguish them from APFCs and => pseudocysts. PNPFCs contain both fluid and necrotic contents to varying degrees. In PNPFCs, there exists a continuum from the initial solid necrosis to liquefaction necrosis and eventually infection.
S. Barbu 2011
SEVERE ACUTE PANCREATITIS Scoring Pancreatic/Peripancreatic Fluid Collections Acute peripancreatic fluid collections <4 wk after onset pancreatitis Fluid collection(s) without solid components Occur with IEP Post-necrotic pancreatic/ peripancreatic fluid collections (PNPFCs) Fluid collections containing necrotic components A continuum of liquefaction necrosis Pancreatic and/or peripancreatic necrosis
S. Barbu 2011
Pancreatic pseudocyst APFCs that persists for >4 wk No solid components Thickened wall
Walled off pancreatic necrosis (WOPN) Isolated collection fluid/ necrosis Thickened wall
Synthesis
Acute pancreatitis
Acute Interstitial edematous pancreatitis (IEP) Acute Necrotizing pancreatitis
Pancreatic + peripancreatic necrosis Peripancreatic alone (20%) Pancreatic alone (rare) (sterile or Infected)
2 Phases of evolution
1st Phase 1-2 wks
best described by Clinical parameters
S. Barbu 2011
Synthesis
Fluid / necrotic collections Early: <4wks Acute peri-pancreatic fluid collections Post-necrotic pancreatic/ peripancreatic fluid collections (PNPFCs) Late: >4wks Pancreatic pseudocyst
S. Barbu 2011
Therapy
Remove offending agent (if possible) Supportive !!! #1- pain killers (until pain free)
NG suction for patients with ileus or emesis TPN may be needed
Therapy continued
#3- Narcotic analgesics usually necessary for pain relieftextbooks say Meperidine NO conclusive evidence that morphine has deleterious effect on sphincter of Oddi pressure #4- Urgent ERCP and biliary sphincterotomy within 72 hours improves outcome of severe gallstone pancreatitis
Reduced biliary sepsis, not actual improvement of pancreatic inflammation
Complications
Necrotizing pancreatitis
Significantly increases morbidity & mortality Usually found on CT with IV contrast
Pseudocysts
Suggested by persistent pain or continued high amylase levels (may be present for 4-6 wks afterward) Cyst may become infected, rupture, hemorrhage or obstruct adjacent structures
Asymptomatic, non-enlarging pseudocysts can be watched and followed with imaging Symptomatic, rapidly enlarging or complicated pseudocysts need to be decompressed
S. Barbu 2011
Complications continued #2
Infection
Many areas for concern: abscess, pancreatic necrosis, infected pseudocyst, cholangitis, and aspiration pneumonia -> SEPSIS may occur If concerned, obtain cultures and start broadspectrum antimicrobials (appropriate for bowel flora) In the absence of fever or other clinical evidence for infection, prophylactic antibiotics is not indicated
Renal failure
Severe intravascular volume depletion or acute tubular necrosis may lead to ARF
S. Barbu 2011
Complications continued #3
Pulmonary
Atelectasis, pleural effusion, pneumonia and ARDS can develop in severe cases
Other
Metabolic disturbances
hypocalcemia, hypomagnesemia, hyperglycemia
GI bleeds
Stress gastritis
Fistula formation
S. Barbu 2011
Prognosis
85-90% mild, self-limited
Usually resolves in 3-7 days
S. Barbu 2011
Mild acute pancreatitis = No indication for surgery. A correct conservative treatment needed (prevent evolution to SAP) Severe acute nectorizing pancreatitis, Surgery indications: -Infected necrosis (or infected pancreatic fluid collections) -Extension of necrosis to neighbouring organs => acute abdomen -intestinal infarction, - perforation of colon, stomach, duoenum, etc - hemorrhage that can not be resolved by embolization - Abdominal Compartment syndrome resistant to conservative treatment
S. Barbu 2011
S. Barbu 2011
Infected pancreatic and peri-pancreatic necrosis = Most frequent Indication for surgery.
1 When do we suspect infected necrosis presence? - Septic Syndrome: fever, bad general condition - + cultures from blood - CECT = air in the fluid collections 2 How do we have a Confirmation of Infected necrosis? -Fine needle aspiration (US or CT guided) + culture -(sensitivity > 90%; can produce iatrogenic infection)
S. Barbu 2011
S. Barbu 2011
How do we Treat Infected necrosis - Percutaneous US or CT guided drainage - endoscopic drainage - Surgical drainage - laparoscopy - open surgery Patients with Infected necrosis, but: - good general condition - reduced signs of sepsis => Can be treated conservatively as long as possible (Antibiotics according to the antibiogram)
S. Barbu 2011
S. Barbu 2011
Surgical procedures
Surgical treatment = Necrozectomy - aims: - extirpation of all (almost all) necrotic tissue - drain infected collections - minimize the risk of complications (hemorrhage, digestive fistulas) - ensure a solid abdominal wall
S. Barbu 2011
Surgical procedures
Open Surgical treatment = Necrozectomy, followed by -abdominal wall closure & Continous lavage -laparostomy
S. Barbu 2011
Surgical procedures
Open Surgical treatment = Necrozectomy, followed by -abdominal wall closure & Continous lavage -laparostomy
S. Barbu 2011
- Drainage by Laparoscopy (retroperitoneal, posterior) -Endoscopic drainage (trans-gastric) -Percutaneous US or CT guided drainage
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
Communicating collections
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
S. Barbu 2011
Pancreatic Pseudocyst
S. Barbu 2011
Pancreatic Pseudocyst
A fluid collection contained within a welldefined capsule of fibrous or granulation tissue or a combination of both Does not possess an epithelial lining Persists > 4 weeks May develop in the setting of acute or chronic pancreatitis
Bradley III et al. A clinically based classification system for acute pancreatitis: summary S. Barbu 2011 of the International Symposium on Acute Pancreatitis, Arch Surg. 1993;128:586-590
Pancreatic Pseudocyst
Most common cystic lesions of the pancreas, accounting for 75-80% of such masses Location Lesser peritoneal sac in proximity to the pancreas Large pseudocysts can extend into the paracolic gutters, pelvis, mediastinum, neck or scrotum
May be loculated
S. Barbu 2011
Composition
Thick fibrous capsule not a true epithelial lining Pseudocyst fluid
Similar electrolyte concentrations to plasma High concentration of amylase, lipase, and enterokinases such as trypsin
S. Barbu 2011
Pathophysiology
Pancreatic ductal disruption 2 to
Acute pancreatitis Necrosis Chronic pancreatitis Elevated pancreatic duct pressures from strictures or ductal calculi Trauma Ductal obstruction and pancreatic neoplasms
S. Barbu 2011
Presentation
Symptoms
Abdominal pain > 3 weeks (80 90%) Nausea / vomiting Early satiety Bloating, indigestion
Signs
Tenderness Abdominal fullness
Cohen et al: Pancreatic pseudocyst. In: Cameron JL, ed. Current Surgical Therapy. 7th S. Barbu 2011 543-7 ed.; 2001:
Diagnosis
CT scan MRI / MRCP Ultrasonography Endoscopic Ultrasonography (EUS) ERCP
S. Barbu 2011
S. Barbu 2011
Sonographic evaluation
S. Barbu 2011
S. Barbu 2011
Complications
Infection
S/S Fever, worsening abd pain, systemic signs of sepsis CT Thickening of fibrous wall or air within the cavity
GI obstruction Perforation Hemorrhage Thrombosis SV (most common) Pseudoaneurysm formation Splenic artery (most common), GDA, PDA
S. Barbu 2011
Treatment
Initial
Treat pain TPN Octreotide
S. Barbu 2011
Intervention
Indications for drainage
Presence of symptoms (> 6 wks) Enlargement of pseudocyst ( > 6 cm) Complications Suspicion of malignancy
Intervention
Percutaneous drainage Endoscopic drainage Surgical drainage
S. Barbu 2011
Percutaneous Drainage
Continuous drainage until output < 50 ml/day + amylase activity
Failure rate 16% Recurrence rates 7%
Complications
Conversion into an infected pseudocyst (10%) Catheter-site cellulitis Damage to adjacent organs Pancreatico-cutaneous fistula GI hemorrhage
Endoscopic Management
Indications Mature cyst wall < 1 cm thick Adherent to the duodenum or posterior gastric wall Previous abd surgery or significant comorbidities Contraindications Bleeding dyscrasias Gastric varices Acute inflammatory changes that may prevent cyst from adhering to the enteric wall CT findings Thick debris Multiloculated pseudocysts
S. Barbu 2011
Endoscopic Drainage
Transenteric drainage
Cystogastrostomy Cystoduodenostomy
Transpapillary drainage
40-70% of pseudocysts communicate with pancreatic duct ERCP with sphincterotomy, balloon dilatation of pancreatic duct strictures, and stent placement beyond strictures
S. Barbu 2011
Surgical Options
Excision
Tail of gland & a/w proximal strictures distal pancreatectomy & splenectomy Head of gland with strictures of pancreatic or bile ducts pancreaticoduodenectomy
Cystoduodenostomy
Can be complicated by duodenal fistula and bleeding at anastomotic site
Nealon et al, Analysis of surgical success in preventing recurrent acute exacerbations in chronic pancreatitis. S. Barbu 2011 Ann Surg. 2001;233:793800
Laparoscopic Management
The interface b/w the cyst and the enteric lumen must be 5 cm for adequate drainage Approaches
Pancreatitis 2 to biliary etiology extraluminal approach w/ concurrent laparoscopic cholecystectomy Non-biliary origin intraluminal (combined laparoscopic/endoscopic) approach
S. Barbu 2011
Enucleation of Pseudocyst
S. Barbu 2011